TY - JOUR
T1 - Lysophosphatidic acid increases the proliferation and migration of adipose-derived stem cells via the generation of reactive oxygen species
AU - Kang, Sangjin
AU - Han, Juhee
AU - Song, Seung Yong
AU - Kim, Won Serk
AU - Shin, Soyoung
AU - Kim, Ji Hye
AU - Ahn, Hyosun
AU - Jeong, Jin Hyun
AU - Hwang, Sung Joo
AU - Sung, Jong Hyuk
PY - 2015/10/1
Y1 - 2015/10/1
N2 - Phospholipid derivatives, such as lysophosphatidic acid (LPA), exhibit mitogenic effects on mesenchymal stem cells; however, the molecular mechanism underlying this stimulation has yet to be identified. The aims of the present study were as follows: To evaluate the stimulatory effects of LPA on the proliferation and migration of adipose-derived stem cells (ASCs); to study the association between reactive oxygen species (ROS) and LPA signaling in ASCs; and to investigate the microRNAs upregulated by LPA treatment in ASCs. The results of the present study demonstrated that LPA increased the proliferation and migration of ASCs, and acted as a mitogenic signal via extracellular signal-regulated kinases 1/2 and the phosphoinositide 3-kinase/Akt signaling pathways. The LPA1 receptor is highly expressed in ASCs, and pharmacological inhibition of it by Ki16425 significantly attenuated the proliferation and migration of ASCs. In addition, LPA treatment generated ROS via NADPH oxidase 4, and ROS were able to function as signaling molecules to increase the proliferation and migration of ASCs. The induction of ROS by LPA treatment also upregulated the expression of miR-210. A polymerase chain reaction array assay demonstrated that the expression levels of adrenomedullin and Serpine1 were increased following treatment with LPA. Furthermore, transfection with Serpine1-specific small interfering RNA attenuated the migration of ASCs. In conclusion, the present study is the first, to the best of our knowledge, to report that ROS generation and miR-210 expression are associated with the LPA-induced stimulation of ASCs, and that Serpine1 mediates the LPA-induced migration of ASCs. These results further suggest that LPA may be used for ASC stimulation during stem cell expansion.
AB - Phospholipid derivatives, such as lysophosphatidic acid (LPA), exhibit mitogenic effects on mesenchymal stem cells; however, the molecular mechanism underlying this stimulation has yet to be identified. The aims of the present study were as follows: To evaluate the stimulatory effects of LPA on the proliferation and migration of adipose-derived stem cells (ASCs); to study the association between reactive oxygen species (ROS) and LPA signaling in ASCs; and to investigate the microRNAs upregulated by LPA treatment in ASCs. The results of the present study demonstrated that LPA increased the proliferation and migration of ASCs, and acted as a mitogenic signal via extracellular signal-regulated kinases 1/2 and the phosphoinositide 3-kinase/Akt signaling pathways. The LPA1 receptor is highly expressed in ASCs, and pharmacological inhibition of it by Ki16425 significantly attenuated the proliferation and migration of ASCs. In addition, LPA treatment generated ROS via NADPH oxidase 4, and ROS were able to function as signaling molecules to increase the proliferation and migration of ASCs. The induction of ROS by LPA treatment also upregulated the expression of miR-210. A polymerase chain reaction array assay demonstrated that the expression levels of adrenomedullin and Serpine1 were increased following treatment with LPA. Furthermore, transfection with Serpine1-specific small interfering RNA attenuated the migration of ASCs. In conclusion, the present study is the first, to the best of our knowledge, to report that ROS generation and miR-210 expression are associated with the LPA-induced stimulation of ASCs, and that Serpine1 mediates the LPA-induced migration of ASCs. These results further suggest that LPA may be used for ASC stimulation during stem cell expansion.
UR - http://www.scopus.com/inward/record.url?scp=84940516072&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84940516072&partnerID=8YFLogxK
U2 - 10.3892/mmr.2015.4023
DO - 10.3892/mmr.2015.4023
M3 - Article
C2 - 26134517
AN - SCOPUS:84940516072
SN - 1791-2997
VL - 12
SP - 5203
EP - 5210
JO - Molecular Medicine Reports
JF - Molecular Medicine Reports
IS - 4
ER -